These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10852385)

  • 1. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
    Puppo F; Brenci S; Contini P; Bignardi D; Hamby CV; Filaci G; Ghio M; Scudeletti M; Picciotto A; Indiveri F; Ferrone S
    Tissue Antigens; 2000 Apr; 55(4):333-41. PubMed ID: 10852385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotype.
    Puppo F; Bignardi D; Contini P; Hamby CV; Brenci S; Lanza L; Ghio M; Scudeletti M; Indiveri F; Ferrone S
    Tissue Antigens; 1999 Mar; 53(3):253-62. PubMed ID: 10203018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.
    Puppo F; Torre F; Contini P; Ghio M; Brenci S; Brizzolara R; Sinelli N; Campo N; Indiveri F; Picciotto A
    J Clin Immunol; 2000 Nov; 20(6):486-90. PubMed ID: 11202239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
    Wang Z; Arienti F; Parmiani G; Ferrone S
    Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
    Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
    Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation.
    Filaci G; Contini P; Brenci S; Lanza L; Scudeletti M; Indiveri F; Puppo F
    Tissue Antigens; 1995 Aug; 46(2):117-23. PubMed ID: 7482504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction by human interferon and murine h-2l(d) gene of the surface expression of endogenous hla class-I free heavy-chains in hct human colon-carcinoma cells, deficient in Beta-2-microglobulin.
    Simile M; Calorini L; Ryan M; Gattonicelli S
    Int J Oncol; 1994 Aug; 5(2):181-8. PubMed ID: 21559573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome.
    DeVito-Haynes LD; Jankowska-Gan E; Meyer KC; Cornwell RD; Zeevi A; Griffith B; Dauber J; Iacono A; Burlingham WJ; Love RB
    Hum Immunol; 2000 Dec; 61(12):1370-82. PubMed ID: 11163095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
    Parolini F; Biswas P; Serena M; Sironi F; Muraro V; Guizzardi E; Cazzoletti L; Scupoli MT; Gibellini D; Ugolotti E; Biassoni R; Beretta A; Malnati M; Romanelli MG; Zipeto D
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G; Contini P; Setti M; Cagnati P; Villa R; Lantieri F; Indiveri F; Puppo F
    Hum Immunol; 2007 Nov; 68(11):894-900. PubMed ID: 18082568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.
    Perosa F; Prete M; Luccarelli G; Favoino B; Ferrone S; Dammacco F
    Hum Immunol; 1999 Nov; 60(11):1058-66. PubMed ID: 10600003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
    Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
    J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?
    Puppo F; Picciotto A; Brenci S; Varagona G; Scudeletti M; Ghio M; Balestra V; Celle G; Indiveri F
    J Clin Immunol; 1995 Jul; 15(4):179-84. PubMed ID: 7593464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity.
    Bresciani A; Pirozzi G; Spera M; Lombardi ML; Ambrosone L; Migliaresi S; Ferrone S; Manzo C
    Tissue Antigens; 1998 Jul; 52(1):44-50. PubMed ID: 9714473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
    Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
    Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.